To better understand BKPyV replication and ways to prevent it, researchers in the UAB Department of Microbiology have published a single-cell analysis of BKPyV infection in primary kidney cells. Their ...

As the world recovers from the economic and social impacts of COVID-19, researchers like Mattia Bacca continue to study SARS-CoV-2 and related viruses to be better prepared for future pandemics. Dr.

Influenza D virus infects human airway cells efficiently and evades early immune responses, raising concerns over zoonotic ...

Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy (ART). The ...

In a recent study posted to the bioRxiv* server, researchers used a non-human primate model to show that Sotrovimab, a commercial monoclonal antibody (mAb) also known as Xevudy, was fully effective ...

Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...

Every winter, respiratory syncytial virus sends tens of thousands of U.S. infants to the hospital, filling pediatric ICU beds ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-Cov-2's molecular ...

BK polyomavirus, or BKPyV, is a major cause of kidney transplant failure. There are no effective drugs to treat BKPyV. Research reveals new aspects of BKPyV replication, offering possible drug targets ...

BIRMINGHAM, Ala. – BK polyomavirus, or BKPyV, is a major cause of kidney transplant failure. There are no effective drugs to treat BKPyV. Research at the University of Alabama at Birmingham reveals ...